Iustitias vestras iudicabo – European Commision’s action against Poland over the prohibition of pharmacy advertising
DOI:
https://doi.org/10.15290/eejtr.2023.07.01.12Abstract
In July 2023 the European Commission has announced bringing an action to the Court of Justice of the European Union against Poland. The action concerns on the functioning of the prohibition of pharmacy advertising in Polish law, which leads to the question - whether and how such prohibition may violate European law. The objective of this research paper is to give, in particular for a foreign reader, a general overview of the prohibition of pharmacy advertising institution, as well as the proceedings conducted by the European Commission under Art. 258 of the Treaty on the Functioning of the European Union against Poland. The other objective of this paper is to conclude whether there are existing any alternatives to resolve dispute between the Commission and Poland, without a necessity for bringing an action to the Court and also what are the possible consequences of not using them. The author of the paper shares his remarks on one of the allegations presented in the European Commission's press release.
Downloads
References
Bruggeman, I.G.J., & Verschueren, Ch. (2019). Protectionism in Central and Eastern Europe and the EU Internal Market: the case of retail. In: W. Heusel & JP. Rageade (eds), The Authority of EU Law. Do We Still Believe in It? (pp. 169-191). Springer, Berlin-Heidelberg. https://doi.org/10.1007/978-3-662-58841-3_14.
Case C‑339/15 (2017, May 4). Judgement of the Court, Request for a preliminary ruling under Article 267 TFEU from the Nederlandstalige rechtbank van eerste aanleg te Brussel, strafzaken (Dutch-language Court of First Instance, Criminal Section, Brussels, Belgium), made by decision of 18 June 2015, received at the Court on 7 July 2015, in the criminal proceedings brought against. ECLI:EU:C:2017:335.
Case C-405/98 (2001, March 8). Judgement of the Court, Reference to the Court under Article 177 of the EC Treaty (now Article 234 EC) by the Stockholms Tingsrätt, Sweden, for a preliminary ruling in the proceedings pending before that court between Konsumentombudsmannen (KO) and Gourmet International Products AB (GIP) on the interpretation of Articles 30, 36, 56 and 59 of the EC Treaty (now, after amendment, Articles 28 EC, 30 EC, 46 EC and 49 EC). ECLI:EU:C:2001:135.
Case C‑530/20 (2022, December 22). Judgement of the Court, Request for a preliminary ruling under Article 267 TFEU from the Latvijas Republikas Satversmes tiesa (Constitutional Court, Latvia), made by decision of 6 October 2020, received at the Court on 20 October 2020, in the proceedings ‘EUROAPTIEKA’ SIA ECLI:EU:C:2022:1014.
Communication from the Commission — EU law: Better results through better application (2017, January 19). 2017/C 18/02. Retrieved from: https://eur-lex.europa.eu/legal-content/PL/TXT/?uri=uriserv%3AOJ.C_.2017.018.01.0010.01.ENG&toc=OJ%3AC%3A2017%3A018%3ATOC.
Consolidated version of the Treaty on the Functioning of the European Union (2007, December 13). OJ C 326, 26.10.2012, p. 47–390 (GA).
Dończyk, M., & Stupak, M. (2020). Reklama apteki: Praktyczny przewodnik po możliwych formach aktywności: czy naprawdę wszystko jest zabronione?. Wolters Kluwer.
Druk sejmowy nr 238 [Parliamentary document No. 238] (2020, February 3). Retrived from: https://www.sejm.gov.pl/Sejm9.nsf/druk.xsp?nr=238.
European Comission. (2010, March 3). System EU PILOT – szybkie odpowiedzi na skargi od obywateli i przedsiębiorców. Retrieved from: https://ec.europa.eu/commission/presscorner/detail/pl/IP_10_226.
European Comission. (2023, July 14). Usługi: Komisja podjęła decyzję o skierowaniu sprawy przeciwko Polsce do Trybunału Sprawiedliwości UE w związku z zakazem reklamy aptek i ich działalności. Retrieved from: https://ec.europa.eu/commission/presscorner/detail/pl/ip_23_3528.
Hellwig, HJ. (2019). The authority of EU law: What does it require and why is it fading?. In: W. Heusel & JP. Rageade (eds), The Authority of EU Law. Do We Still Believe in It? (pp. 149–162). Springer, Berlin-Heidelberg. https://doi.org/10.1007/978-3-662-58841-3_12.
Konfederacja Lewiatan. (2023, July 19). Kolejny etap batalii o zniesienie zakazu komunikacji aptek z pacjentem. Retrieved from: https://lewiatan.org/kolejny-etap-batalii-o-zniesienie-zakazu-komunikacji-aptek-z-pacjentem/.
Kozik, K., & Pietryga, E. (2014, January 3). Przedsiębiorca powinien umieć odróżnić informację od reklamy. Rzeczpospolita. Retrieved August 10, 2023, from https://www.rp.pl/prawo-w-firmie/art5230911-przedsiebiorca-powinien-umiec-odroznic-informacje-od-reklamy
Moens, G., & Trone, J. (2010). Free Movement of Persons and Services. In: Commercial Law of the European Union. Ius Gentium: Comparative Perspectives on Law and Justice, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8774-4_3.
Odpowiedź Ministra Zdrowia na zapytanie nr 9544 w sprawie nowelizacji art. 94a ust. 1 ustawy – Prawo farmaceutyczne [Minister of Health’s answer to Parliamentary Question No. 9544 regarding the amendment of the art. 94a(1) of the Pharmaceutical Law Act] (2019, July 24). PLO.070.43.2019.MP. Retrived from: https://sejm.gov.pl/Sejm8.nsf/interpelacja.xsp?typ=ZAP&nr=9544&view=2.
Olszewski, W.L. (2016). Art. 94a. In R. Dybka (Ed.), Prawo farmaceutyczne. Komentarz (pp. 958–981). Wolters Kluwer. https://sip.lex.pl/#/commentary/587711450/508890/olszewski-wojciech-l-red-prawo-farmaceutyczne-komentarz?cm=URELATIONS.
Półtorak, N. (2012). Art. 258. In D. Kornobis-Romanowska, J. Łacny & A. Wróbel (Eds.), Traktat o funkcjonowaniu Unii Europejskiej. Komentarz. Tom III (art. 223-358). Wolters Kluwer. https://sip.lex.pl/#/commentary/587326818/124258/kornobis-romanowska-dagmara-red-lacny-justyna-red-wrobel-andrzej-red-traktat-o-funkcjonowaniu...?cm=URELATIONS.
Rozporządzenie Prezesa Rady Ministrów w sprawie “Zasad techniki prawodawczej” [Regulation of the Prime Minister on “Principles of legislative technique”] (2002, June 20). Dz.U. 2002 nr 100 poz. 908.
Sikora, A. (2015). Rozdział 1. Skargi o stwierdzenie uchybienia prawu unijnemu przez państwo członkowskie (art. 258, 259 oraz 260 TFUE). In A. Łazowski, & A. Zawidzka-Łojek (Eds.), Instytucje i porządek prawny Unii Europejskiej (pp. 235-248). Instytut Wydawniczy EuroPrawo.
Skrzydło-Tefelska, E. (2012). Art. 56. In D. Miąsik, N. Półtorak & A. Wróbel (Eds.), Traktat o funkcjonowaniu Unii Europejskiej. Komentarz. Tom I (art. 1-89). Wolters Kluwer. https://sip.lex.pl/#/commentary/587327130/124570/miasik-dawid-red-poltorak-nina-red-wrobel-andrzej-red-traktat-o-funkcjonowaniu-unii-europejskiej...?cm=URELATIONS.
Śmigulska-Wojciechowska, A. (Ed.) (2020). Zakaz reklamy apteki. Wiedza i Praktyka.
Stefańczyk-Kaczmarczyk, J. (2016). Art. 94a. In M. Kondrat (Ed.), Prawo farmaceutyczne. Komentarz (pp. 1114-1124). Wolters Kluwer. https://sip.lex.pl/#/commentary/587252184/505028/kondrat-mariusz-red-prawo-farmaceutyczne-komentarz-wyd-ii?cm=URELATIONS.
Świerczyński, M. (2020). 7.4.1. Obrót detaliczny. In M. Krekora, M. Świerczyński, & E. Traple (Eds.), Prawo farmaceutyczne (pp. 511-528). Warszawa: Wolters Kluwer.
Ustawa Kodeks postępowania administracyjnego [The Code of Administrative Procedure Act] (1960, June 14). t.j. Dz. U. z 2023 r. poz. 775.
Ustawa o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych [Act on medicine, foodstuffs intended for particular nutritional uses and medical devices reimbursement] (2011, May 12). Dz.U. 2011 Nr 122 Poz. 696.
Ustawa o zawodzie farmaceuty [Act on proffesion of pharmacist] (2020, December 10). t.j. Dz. U. z 2022 r. poz. 1873.
Ustawa Prawo farmaceutyczne [Pharmaceutical Law Act ] (2001, September 6). t.j. Dz. U. 2022 poz. 2301.
Wiśniewska, A. D. (2018). Rozdział XXVIII. Zakaz reklamy aptek jako przykład nieuzasadnionej ingerencji w swobodę działalności gospodarczej?. In E. Kruk, G. Lubeńczuk & M. Zdyb (Eds.), Dysfunkcje publicznego prawa gospodarczego (pp. 423-433). C. H. Beck.
Wiszniewska, J. (2019). Rozdział V. Kontrowersje związane z zakazem reklamy aptek i ich działalności. In Zakaz reklamy aptek i ich działalności. C. H. Beck, https://legalis.pl/.
Wyrok Naczelnego Sądu Administracyjnego [Judgment of the Supreme Administrative Court], No. II GSK 568/19. (2022, October 6). https://sip.lex.pl/#/jurisprudence/523510546/1/ii-gsk-568-19-pojecie-reklamy-aptek-niedozwolona-reklama-apteki-wyrok-naczelnego-sadu...?keyword=reklama%20apteki&cm=SREST.
Wyrok Sądu Najwyższego [Judgment of the Supreme Court], No. II CSK 289/07. (2007, October 2). https://sip.lex.pl/#/jurisprudence/520435501?cm=DOCUMENT.
Wyrok Wojewódzkiego Sądu Administracyjnego w Warszawie [Judgment of the Voivodeship Administrative Court in Warsaw], No. VI SA/Wa 173/14. (2014, September 1). https://sip.lex.pl/#/jurisprudence/521690656/1?directHit=true&directHitQuery=VI%20SA%2FWa%20173%2F14.
Wyrok Wojewódzkiego Sądu Administracyjnego w Warszawie [Judgment of the Voivodeship Administrative Court in Warsaw], No. VI SA/Wa 250/20. (2020, August 18). https://sip.lex.pl/#/jurisprudence/523411126/1/vi-sa-wa-250-20-umieszczenie-na-rzucajacych-sie-w-oczy-duzych-banerach-nazwy-danej-apteki-i...?keyword=%22art.%2056%20TFUE%22&cm=URELATIONS.
Wyrok Wojewódzkiego Sądu Administracyjnego w Warszawie [Judgment of the Voivodeship Administrative Court in Warsaw], No. VII SA/Wa 1960/07. (2008, February 1). https://sip.lex.pl/#/jurisprudence/520544861/1?directHit=true&directHitQuery=VII%20SA~2FWa%201960~2F07.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Krzysztof Karpowicz
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The Author declares that he or she has created the written work and holds exclusive and unlimited copyright /both moral and property rights/ and guarantees that no third parties have rights to the work.
2. In the view of the Copyright and Related Rights Act, a work must fulfill the following criterion:
a) be a manifestation of creative work,
b) have an individual character („author’s personal stamp”),
c) have a set form.
3. The Author declares that the text has not been previously published (under the same or different title, or as a part of another publication).
4. The Author allows (grants a non-exclusive license) the publishing house of University of Białystok to use the scholarly text to:
- preserve and multiply by means of any technique; save in a digital form with no limitations as to the manner and form of digital preservation;
- upload online with no limitations as to the place and time of access.
5. The Author grants consent for editorial changes made in the work.
6. The Author grants the University of Białystok rights free of charge for the duration of property copyright with no territory limits. The University has the right to grant sublicenses in the acquired rights.
7. Granting a non-exclusive license allows the Author to preserve their rights and allows other parties to make use of the work according to sublicensing agreement with provisions identical as those of Attribution 4.0 Internacional License (CC BY 4.0), available online at: https://creativecommons.org/licenses/by/4.0/. License to all its content published from 2023 and CC BY-NC-ND 4.0 to all its content published from 2017 to 2022.
8. The Agreement has been concluded for an indefinite period of time.
9. Because of costs born in preparation of the work for publishing, the Parties oblige themselves to act in good faith and refrain from declining to grant licenses.
10. To all matters not settled herein, provisions of the Civil Code and Copyright and Related Rights Act of 1994, February 4 shall apply.
11. All disputes shall be resolved by a court of local jurisdiction for the place of seat of University of Białystok.
